8-K - Aytu BioPharma, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

Regulation FD Disclosure. On January 20, 2026, Aytu BioPharma, Inc. (the “Company” or “Aytu”) issued a press release titled “Aytu BioPharma Recaps Investor Day

Regulation Fd

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Exhibit Description 99.1 Press Release dated January 20, 2026 99.2 Investor Day Presentation Dat

Exhibits Only

Source Document

Exhibits (3)

8-K

FORM 8-K

99.1

EXHIBIT 99.1

99.2

EXHIBIT 99.2